Michinori Kohara Selected Research

Michinori Kohara Research Topics

Disease

65	Infections 01/2024 - 08/2003
12	COVID-19 03/2023 - 12/2020
8	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 11/2003
7	Inflammation (Inflammations) 10/2023 - 03/2011
7	Chronic Hepatitis B 03/2023 - 02/2003
7	Virus Diseases (Viral Diseases) 01/2023 - 02/2003
7	Fibrosis (Cirrhosis) 10/2022 - 01/2012
7	Hepatitis C 06/2015 - 03/2004
6	Hepatitis B 10/2023 - 01/2017
6	Liver Cirrhosis (Hepatic Cirrhosis) 10/2023 - 08/2003
6	Liver Diseases (Liver Disease) 10/2022 - 08/2003
6	Chronic Hepatitis C 09/2013 - 09/2003
5	Persistent Infection 05/2020 - 01/2006
4	Pneumonia (Pneumonitis) 11/2021 - 11/2008
4	Neoplasms (Cancer) 01/2020 - 11/2003
4	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016 - 01/2012
3	Dengue (Dengue Fever) 12/2023 - 07/2018
3	Viremia 12/2023 - 02/2004
3	Severe Acute Respiratory Syndrome 01/2022 - 01/2007
3	Human Influenza (Influenza) 11/2021 - 06/2012
3	Influenza in Birds (Avian Flu) 10/2020 - 06/2012
2	Communicable Diseases (Infectious Diseases) 03/2024 - 01/2023
2	Coinfection 06/2023 - 11/2010
2	Hepatitis A (Hepatitis, Infectious) 01/2019 - 08/2006
2	Fatty Liver 01/2013 - 01/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2011 - 12/2010
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2024
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Coronavirus Infections 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 11/2022
1	Reinfection 11/2022
1	COVID-19 reinfection 11/2022
1	Cholestasis 10/2022

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 10/2023 - 01/2007
19	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2003
12	InterferonsIBA 01/2024 - 08/2003
10	Antiviral Agents (Antivirals)IBA 12/2023 - 08/2003
9	Small Interfering RNA (siRNA)IBA 01/2024 - 08/2006
8	Immunoglobulin G (IgG)IBA 03/2023 - 01/2022
8	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2003
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2003
7	CytokinesIBA 01/2022 - 11/2008
5	Interferon Type IIBA 01/2024 - 12/2004
5	ICG 001IBA 10/2023 - 11/2015
5	CateninsIBA 10/2023 - 11/2015
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2023 - 01/2017
5	AntibodiesIBA 09/2023 - 09/2003
5	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2023 - 01/2017
5	AntigensIBA 11/2019 - 02/2003
4	Therapeutic UsesIBA 10/2023 - 08/2003
4	LipidsIBA 01/2022 - 11/2005
3	mRNA VaccinesIBA 03/2024 - 12/2022
3	Dengue VaccinesIBA 12/2023 - 07/2018
3	Toll-Like Receptor AgonistsIBA 01/2023 - 09/2021
3	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2022 - 11/2015
3	Nucleocapsid ProteinsIBA 02/2022 - 11/2008
3	Peptides (Polypeptides)IBA 11/2021 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2016 - 11/2012
3	Complementary DNA (cDNA)IBA 01/2015 - 03/2004
2	Hepatitis B Core AntigensIBA 03/2023 - 11/2019
2	Immunoglobulin A (IgA)IBA 01/2023 - 02/2022
2	Immunoglobulin M (IgM)IBA 01/2023 - 02/2022
2	Neutralizing AntibodiesIBA 11/2022 - 04/2014
2	Carrier Proteins (Binding Protein)IBA 10/2022 - 11/2015
2	Circular DNAIBA 01/2022 - 01/2022
2	ChemokinesIBA 01/2022 - 12/2006
2	Immunologic Factors (Immunomodulators)IBA 09/2021 - 04/2014
2	A-Form DNA (A-DNA)IBA 03/2017 - 12/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 01/2012
2	Caspase 3 (Caspase-3)IBA 06/2012 - 05/2011
2	SphingolipidsIBA 01/2012 - 11/2005
2	Monoclonal AntibodiesIBA 10/2011 - 12/2009
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2011 - 12/2010
1	Ubiquitin-Specific ProteasesIBA 01/2024
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023
1	Broadly Neutralizing AntibodiesIBA 10/2023
1	Amino Acids FDA Link 10/2023
1	CollagenIBA 10/2023
1	Choline (Choline Chloride)IBA 10/2023
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 09/2023
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2023
1	Pattern Recognition ReceptorsIBA 06/2023
1	A-factor (Streptomyces)IBA 03/2023
1	Prednisolone (Predate)FDA LinkGeneric 02/2023
1	SteroidsIBA 02/2023
1	Vaccine AdjuvantsIBA 01/2023
1	ParaffinIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	ATP-Binding Cassette Sub-Family B Member 4IBA 10/2022
1	Bile Acids and Salts (Bile Acids)IBA 10/2022

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2005
2	Renal Dialysis (Hemodialysis) 11/2022 - 02/2022
2	Ligation 10/2022 - 11/2015
2	Immunotherapy 12/2020 - 12/2013
2	Drug Therapy (Chemotherapy) 09/2017 - 06/2013
1	Stem Cell Transplantation 02/2023
1	Critical Care (Surgical Intensive Care) 11/2022